Aberrant DNA methylation of CpG islands occurred frequently in CRC and associated with transcriptional silencing of key genes. In this study, the CIMP combined with MLH1 or p16 methylation status was determined in CRC patients and correlated with clinicopathological parameters and overall survival. Our data showed that CIMP+ CRCs were identified in 32.9% of cases and that CACNAG1 is the most frequently methylated promoter. When we combined the CIMP with the MLH1 or the p16 methylation status, we found that CIMP-/MLH1-U (37.8%) and CIMP-/p16 -U (35.4%) tumors were the most frequent among the four subtypes. Statistical analysis showed that tumor location, lymphovascular invasion, TNM stage, and MSI differed among the group of patients. Kaplan-Meier analyses revealed differences in overall survival according to the CIMP combined with MLH1 or p16 methylation status. In a multivariate analysis, CIMP/MLH1 and CIMP/p16 methylation statuses were predictive of prognosis, and the OS was longer for patients with tumors CIMP-/MLH1-M, as well as CIMP-/p16 -M. Furthermore, DNMT1 is significantly overexpressed in tumors than in normal tissues as well as in CIMP+ than CIMP- tumors. Our results suggest that tumor classification based on the CIMP status combined with MLH1 or p16 methylation is useful to predict prognosis in CRC patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s12032-017-1007-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Advances in the Diagnosis of Atypical Polypoid Adenomyoma Combining Immunohistochemical and Molecular-Based Approaches: Case Report and Review of the Literature.
Curr Issues Mol Biol
December 2024
Department of Pathology, Analiza, 28001 Madrid, Spain.
Atypical polypoid adenomyoma (APA) is a benign uterine lesion with a premalignant potential and occurs in women of reproductive age. The histological pattern is characterized by irregular epithelial proliferation and muscular stroma. Based on a case report, we performed a systematic review of the literature to assess the main immunohistochemical and molecular markers that contribute to its differential diagnosis against endometrial adenocarcinoma (EC).
View Article and Find Full Text PDFInfluence of Immunoexpression of Mismatch Repair Complex Proteins on Disease-Free Survival in Non-Surgically Treated Oropharyngeal Squamous Cell Carcinomas.
Head Neck Pathol
November 2024
Laboratory of Oral Pathology, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Article Synopsis
- The study aimed to assess how MMR complex protein expression affects disease-free survival in oropharyngeal squamous cell carcinoma (SCC) patients who were treated non-surgically.
- Data from 85 cases were analyzed, focusing on clinical-pathological information and immunohistochemical markers (MSH2, MSH6, PMS2, MLH1, and p16) to identify correlations with patient outcomes.
- Results showed that loss of MSH2 in p16- tumors led to shorter disease-free survival, while in p16+ tumors, loss of MSH2 was linked to longer survival, indicating that imbalances in MMR proteins play a crucial role in treatment resistance and patient prognosis.
Endometrial serous carcinoma with a corded and hyalinized pattern: a clinicopathological and molecular analysis.
Pathologica
June 2024
Gynecopathology and Breast Pathology Unit, Department of Woman and Child's Health and Public Health Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
A corded and hyalinized pattern has been described in endometrial endometrioid carcinoma. Herein, we describe a clinicopathological and molecular analysis of the first reported case of endometrial serous carcinoma with a corded and hyalinized pattern. A 64-year-old woman underwent hysterectomy and bilateral salpingo-oophorectomy due to a 5.
View Article and Find Full Text PDFThe role of aberrant DNA methylation in cancer initiation and clinical impacts.
Ther Adv Med Oncol
January 2024
Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, VIC, Australia.
Epigenetic alterations, including aberrant DNA methylation, are now recognized as hallmarks of cancer, which can contribute to cancer initiation, progression, therapy responses and therapy resistance. Methylation of gene promoters can have a range of impacts on cancer risk, clinical stratification and therapeutic outcomes. We provide several important examples of genes, which can be silenced or activated by promoter methylation and highlight their clinical implications.
View Article and Find Full Text PDFABERRANT METHYLATION OF CANCER-RELATED GENES IN VIETNAMESE BREAST CANCER PATIENTS: ASSOCIATIONS WITH CLINICOPATHOLOGICAL FEATURES.
Exp Oncol
October 2023
Pathology and Molecular Biology Centre, National Cancer Hospital K, 30 Cau Buou Street, Thanh Tri, Hanoi, Vietnam.
Background: Epigenetic alteration is one of the most common molecular changes identified in the progression of breast cancer (BC).
Aim: To study the frequency and relation between methylation of BRCA1, MLH1, MGMT, GSTP1, APC, RASSF1A, p16, WIF, and EGFR and the clinicopathological features in Vietnamese BC patients.
Materials And Methods: Methylation-specific polymerase chain reaction (MS-PCR) and SPSS 20.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!